Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive Sensitive vs Vismed in Dry Eye
NCT00938704Phase 4Completed
- Sponsor
- Allergan
- Start
- Jun 2009
- Primary completion
- Jun 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose + glycerin in dry eye syndrome (DED), sponsored by Allergan. Started Jun 2009; status: completed.
02
Drugs
carboxymethylcellulose + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00938704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938704.